
STAT+: Eli Lilly’s chief scientist on new obesity drug data, gene editing, and a potential new heart drug
PHILADELPHIA — In a sense, the annual meeting of the American Heart Association wasn’t a…

PHILADELPHIA — In a sense, the annual meeting of the American Heart Association wasn’t a…

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered…
.jpg)
PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding…

PHILADELPHIA — A new study, and the bold doctor who led it, could result in…

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in…